isoxazoles has been researched along with Alveolitis, Fibrosing in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, X; Lu, F; Sun, X; Xu, X | 1 |
| Biancatelli, RMLC; Catravas, JD; Dimitropoulou, C; Marinova, M; Solopov, P | 1 |
| Batteux, F; Cerles, O; Chéreau, C; Chouzenoux, S; Kavian, N; Morin, F; Nicco, C | 1 |
| Barbaro Foschino, MP; Brunetti, ND; Correale, M; Di Biase, M; Lacedonia, D; Montrone, D; Totaro, A | 1 |
| An, MS; Ding, Q; Feng, R; Li, L; Liu, Y; Tang, N; Wang, S; Wei, W; Wen, J; Zhao, Y | 1 |
| Carter, AB; Gu, L; He, C; Larson-Casey, JL; Murthy, S; Ryan, AJ | 1 |
| Bellamy, CO; Dhaun, N; Kluth, DC; MacIntyre, IM | 1 |
| Ewert, R; Opitz, CF | 1 |
| Harada, M; Inokuma, S; Koyama, T; Niiro, H; Ohtani, R; Otsuka, T; Yoshizawa, S | 1 |
2 review(s) available for isoxazoles and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Novelty in treatment of pulmonary fibrosis: pulmonary hypertension drugs and others.
Topics: Antihypertensive Agents; Bosentan; Humans; Isoxazoles; Phenylpropionates; Phosphodiesterase Inhibitors; Pulmonary Fibrosis; Pyridazines; Sulfonamides; Thiophenes | 2013 |
Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Cell Division; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension, Pulmonary; Isoxazoles; Lung; Pulmonary Fibrosis; Sulfonamides; Thiophenes; Vasoconstriction; Vasodilation | 2006 |
7 other study(ies) available for isoxazoles and Alveolitis, Fibrosing
| Article | Year |
|---|---|
SILAC-based proteomic profiling of the suppression of TGF-β1-induced lung fibroblast-to-myofibroblast differentiation by trehalose.
Topics: Actins; Autophagy; beta Catenin; Cell Differentiation; Cell Line; Collagen Type I; Down-Regulation; Fibroblasts; Humans; Imidazoles; Isoxazoles; Lung; Myofibroblasts; Proteomics; Pulmonary Fibrosis; Signal Transduction; Transforming Growth Factor beta1; Trehalose | 2020 |
The HSP90 Inhibitor, AUY-922, Ameliorates the Development of Nitrogen Mustard-Induced Pulmonary Fibrosis and Lung Dysfunction in Mice.
Topics: Animals; Biomarkers; Disease Models, Animal; Extracellular Matrix Proteins; HSP90 Heat-Shock Proteins; Isoxazoles; Lung; Lung Injury; Male; MAP Kinase Signaling System; Mechlorethamine; Mice; Mice, Inbred C57BL; Pulmonary Alveoli; Pulmonary Fibrosis; Resorcinols | 2020 |
Leflunomide prevents ROS-induced systemic fibrosis in mice.
Topics: Animals; Antirheumatic Agents; Autoantibodies; Bleomycin; Cells, Cultured; Disease Models, Animal; Female; Fibrosis; Humans; Hypochlorous Acid; Immunosuppression Therapy; Isoxazoles; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Leflunomide; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Pulmonary Fibrosis; Reactive Oxygen Species; Signal Transduction; Skin; STAT6 Transcription Factor | 2017 |
Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.
Topics: Animals; Bleomycin; Cell Differentiation; Cells, Cultured; Humans; Isoxazoles; Lysophospholipids; Mesenchymal Stem Cells; Mice; Mice, Inbred ICR; Mice, SCID; Mice, Transgenic; Myofibroblasts; Propionates; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid; Signal Transduction | 2014 |
Cu,Zn-Superoxide Dismutase-Mediated Redox Regulation of Jumonji Domain Containing 3 Modulates Macrophage Polarization and Pulmonary Fibrosis.
Topics: Animals; Cell Line; Cell Polarity; Gene Expression Regulation; Humans; Interleukin-4; Isoxazoles; Jumonji Domain-Containing Histone Demethylases; Leflunomide; Macrophage Activation; Macrophages; Mice, Inbred C57BL; Models, Biological; Oxidation-Reduction; Oxidative Stress; Pulmonary Fibrosis; Reactive Oxygen Species; STAT6 Transcription Factor; Superoxide Dismutase-1 | 2016 |
Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
Topics: Amides; Antihypertensive Agents; Atrophy; Biomarkers; Biopsy; Endothelin Receptor Antagonists; Female; Fibrosis; Fumarates; Humans; Hypertension, Renal; Isoxazoles; Kidney; Middle Aged; Proteinuria; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Renin; Scleroderma, Systemic; Thiophenes; Treatment Outcome | 2009 |
Leflunomide-induced lung injury that developed after its withdrawal, coinciding with peripheral blood lymphocyte count decrease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Administration Schedule; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lymphocyte Count; Middle Aged; Pulmonary Fibrosis | 2008 |